Why is it necessary to waive non-compete clauses?

Under Article 209 of the Company Act, it ensures that when directors engage in activities that may compete with the company, they do so legally with the consent of shareholders to manage potential conflicts of interest.

How does this affect investors?

There is no direct financial impact, but it serves as a governance indicator showing that the company is following proper compliance procedures.

Is waiving non-compete clauses common?

Yes, it is a standard governance procedure for listed and public companies in Taiwan to authorize the concurrent roles or investment activities of directors.

[Bonraybio] Announcement of Shareholder Meeting Resolution to Waive Non-Compete Restrictions for Directors and Representatives

Published May 20, 2026 9:00 AM ・ Updated Jun 14, 2026 12:03 AM ・ 3 min read ・ Source: PR Times

Bonraybio announced that at its general shareholder meeting on May 20, 115, it approved the waiver of non-compete restrictions for director Tsai Hsiu-chuan, and independent directors Wang Yu-hsiang and Chou Tien-tai.

1. Date of shareholder resolution: 05/20/115 2. Names and titles of directors permitted to engage in competitive activities: Director: Tsai Hsiu-chuan (Representative of Bo Bang Capital Co., Ltd.) Independent Director: Wang Yu-hsiang Independent Director: Chou Tien-tai 3. Items of competitive activities permitted: Investment in or operation of businesses that are the same as or similar to the company's scope of business. 4. Duration of permitted competitive activities: During the period of tenure as a director of the company. 5. Voting results (explanation based on Article 209 of the Company Act): Approved as proposed by a majority of votes cast by shareholders representing at least two-thirds of issued shares in attendance. 6. Names and titles of directors if the permitted competitive activities involve businesses in Mainland China (enter 'N/A' if not applicable): N/A 7. Name of the company in Mainland China and position held: N/A 8. Address of the business in Mainland China: N/A 9. Business scope of the business in Mainland China: N/A 10. Impact on the company's financial and business operations: N/A 11. Amount and percentage of investment by the director in the Mainland China business: N/A 12. Other matters: None

FACT BOX

Source: PR Times
Category: 人事
Dates in source: 115/05/20

[Bonraybio] Announcement of Shareholder Meeting Resolution to Waive Non-Compete Restrictions for Directors and Representatives

⚡ Key Points

FACT BOX

Editorial & Verification Standards

FAQ

Cite this article — HOW TO CITE

AI CRAWLER ACTIVITY